{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T22:24:33Z","timestamp":1743978273747,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12149-020-01555-7","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T06:03:08Z","timestamp":1609653788000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Applying postoperative radioiodine therapy before 3\u00a0months seems to decrease ablation success in patients with differentiated thyroid carcinoma"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-4778","authenticated-orcid":false,"given":"\u00d6zhan","family":"\u00d6zdo\u011fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015feg\u00fcl","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersoy","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Og\u00fcn","family":"B\u00fclb\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih","family":"G\u00fcray Durak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali \u0130brahim","family":"Sevin\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u0131rat","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet \u00d6mer","family":"\u0130kiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"1555_CR1","unstructured":"National Cancer Institute surveillance, epidemiology, and end results program-cancer stat facts: thyroid cancer. Available at www.seer.cancer.gov\/statfacts\/html\/thyro.html. (Accessed 09 Apr 2020)"},{"key":"1555_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, et al. Controversies, consensus, and collaboration in the Use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29:461\u201370.","journal-title":"Thyroid"},{"key":"1555_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1\u2013133.","journal-title":"Thyroid"},{"key":"1555_CR4","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787\u2013803.","journal-title":"Eur J Endocrinol"},{"key":"1555_CR5","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2019","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2019;19:1167\u2013214.","journal-title":"Thyroid"},{"issue":"26","key":"1555_CR6","first-page":"452","volume":"112","author":"R Paschke","year":"2015","unstructured":"Paschke R, Lincke T, Muller SP, Kreissl MC, Dralle H, Fassnacht M. The treatment of well-differentiated thyroid carcinoma. Dtsch Arztebl Int. 2015;112(26):452\u20138.","journal-title":"Dtsch Arztebl Int"},{"key":"1555_CR7","first-page":"246","volume-title":"Therapeutic nuclear medicine. Medical radiology, online edition","author":"C Reiners","year":"2012","unstructured":"Reiners C, Dietlein M, Verburg F, Luster M. Ablation therapy with radioiodine in adults and children with differentiated thyroid cancer. In: Baum R, editor. Therapeutic nuclear medicine. Medical radiology, online edition. Berlin: Springer; 2012. p. 246\u201355."},{"key":"1555_CR8","unstructured":"National Comprehensive Cancer Network, Inc. Practice guidelines in oncology-v.2.19; 2019. Available at www.nccn.org\/professionals\/physician_gls\/pdf\/thyroid.pdf. (Accessed 16 Sep 2019)"},{"key":"1555_CR9","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.110.081059","volume":"52","author":"T Higashi","year":"2011","unstructured":"Higashi T, Nishii R, Yamada S, Nakamoto Y, Ishizu K, Kawase S, et al. Delayed initial radioactive iodine therapy resulted in poor survival in patients with metastatic differentiated thyroid carcinoma: a retrospective statistical analysis of 198 cases. J Nucl Med. 2011;52:683\u20139.","journal-title":"J Nucl Med"},{"issue":"3","key":"1555_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/cen.12301","volume":"80","author":"S Tsirona","year":"2013","unstructured":"Tsirona S, Vlassopoulou V, Tzanela M, Rondogianni Ph, Ioannidis G, Vassilopoulos Ch, et al. 2013 Impact of early vs late post-operative radioiodine remnant ablation on final outcome in patients with low-risk well differentiated thyroid cancer. Clin Endocrinol. 2013;80(3):459\u201363.","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1555_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1089\/thy.2016.0038","volume":"26","author":"RS Scheffel","year":"2016","unstructured":"Scheffel RS, Zanella AB, Dora JM, Maia AL. Timing of radioactive iodine administration does not influence outcomes in patients with differentiated thyroid carcinoma. Thyroid. 2016;26(11):1623\u20139.","journal-title":"Thyroid"},{"issue":"7","key":"1555_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.4158\/EP151088.OR","volume":"22","author":"P Suman","year":"2016","unstructured":"Suman P, Wang CH, Abadin SHS, Block R, Raghavan V, Moo-Young TA, et al. Timing of radioactive iodine therapy does not impact overall survival in high-risk papillary thyroid carcinoma. Endocr Pract. 2016;22(7):822\u201331.","journal-title":"Endocr Pract"},{"issue":"9","key":"1555_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1177\/000313481608200942","volume":"82","author":"P Suman","year":"2016","unstructured":"Suman P, Wang CH, Moo-Young TA, Prinz RA, Winchester DJ. Timing of adjuvant radioactive iodine therapy does not affect overall survival in low- and intermediate-risk papillary thyroid carcinoma. Am Surg. 2016;82(9):807\u201314.","journal-title":"Am Surg"},{"issue":"4","key":"1555_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/cen.13551","volume":"88","author":"H Li","year":"2018","unstructured":"Li H, ZhangY-Q WC, Zhang X, Li X, Lin Y-S. Delayed initial radioiodine therapy related to incomplete response in low- to intermediate-risk differentiated thyroid carcinoma. Clin Endocrinol. 2018;88(4):601\u20136.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"1555_CR15","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1210\/jc.2004-0739","volume":"89","author":"E Mazzaferri","year":"2004","unstructured":"Mazzaferri E. A randomized trial of remnant ablation\u2014in search of an impossible dream? J Clin Endocrinol Metab. 2004;89(8):3662\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1555_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, et al. Controversies, consensus, and collaboration in the use of 131I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29(4):461\u201370.","journal-title":"Thyroid"},{"key":"1555_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/0-387-25714-4_16","volume-title":"Essentials of thyroid cancer management","author":"DB Villaret","year":"2005","unstructured":"Villaret DB, Amdur RJ, Mazzaferri EL. A total thyroidectomy rarely removes all thyroid tissue. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. 1st ed. New York: Springer Science+Business Media, Inc.; 2005. p. 143\u20136.","edition":"1"},{"issue":"2","key":"1555_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1530\/eje.0.1500105","volume":"150","author":"M Schlumberger","year":"2014","unstructured":"Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol. 2014;150(2):105\u201312.","journal-title":"Eur J Endocrinol"},{"key":"1555_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/0-387-25714-4_37","volume-title":"Essentials of thyroid cancer management","author":"EL Mazzaferri","year":"2005","unstructured":"Mazzaferri EL, Amdur RJ, Schmalfuss IM. Follow-up protocol and treatment of recurrent or metastatic differentiated thyroid cancer. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. 1st ed. New York: Springer Science+Business Media, Inc.; 2005. p. 287\u2013341.","edition":"1"},{"issue":"supplement1","key":"1555_CR20","first-page":"2054","volume":"53","author":"F Feng","year":"2012","unstructured":"Feng F, Wang H. Lymph node metastases of differentiated thyroid cancer more frequently develops into non-iodine-avid lesions than lung or bone metastases. J Nucl Med. 2012;53(supplement1):2054.","journal-title":"J Nucl Med"},{"issue":"8","key":"1555_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/01.mnm.0000169380.92270.73","volume":"26","author":"M Medvedec","year":"2005","unstructured":"Medvedec M. Thyroid stunning in vivo and in vitro. Nucl Med Commun. 2005;26(8):731\u20135.","journal-title":"Nucl Med Commun"},{"key":"1555_CR22","first-page":"203","volume-title":"Thyroid cancer","author":"B Shapiro","year":"2005","unstructured":"Shapiro B, Freitas J, Gross M. Follow-up of patients with well-differentiated thyroid cancer. In: Biersack HJ, Gr\u00fcnwald F, editors. Thyroid cancer. 2nd ed. New York: Springer-Verlag; 2005. p. 203\u20135.","edition":"2"},{"key":"1555_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/0-387-25714-4_7","volume-title":"Essentials of thyroid cancer management","author":"RJ Amdur","year":"2005","unstructured":"Amdur RJ, Mazzaferri EL. Thyroid stunning. In: Amdur RJ, Mazzaferri EL, editors. Essentials of thyroid cancer management. 1st ed. New York: Springer Science+Business Media Inc; 2005. p. 55\u20139.","edition":"1"},{"key":"1555_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4158\/EP14462.DSC","volume":"21","author":"BC Stack","year":"2015","unstructured":"Stack BC, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, et al. American association of clinical endocrinologists and American college of endocrinology disease state clinical review: postoperative hypoparathyroidism\u2014definitions and management. Endocr Pract. 2015;21:674\u2013768.","journal-title":"Endocr Pract"},{"key":"1555_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s13139-019-00608-8","volume":"53","author":"J Krajewska","year":"2019","unstructured":"Krajewska J, Jarzab M, Kukulska A, Czarniecka A, Roskosz J, Puch Z, et al. Postoperative radioiodine treatment within 9 months from diagnosis significantly reduces the risk of relapse in low-risk differentiated thyroid carcinoma. Nucl Med Mol Imaging. 2019;53:320\u20137.","journal-title":"Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-020-01555-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T21:46:03Z","timestamp":1613771163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-020-01555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1555"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01555-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"23 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}